![1]()
News
New updates for Choosing Wisely in hospitalized patients with infection
February 1, 2021
Which new Choosing Wisely recommendations should hospitalists incorporate into their practice to avoid unnecessary testing, reduce harm, and lower cost?
News
Ceftolozane-tazobactam found effective in critically ill patients with Pseudomonas aeruginosa infections
January 29, 2021
The primary outcome of the study was to assess the efficacy and toxicity of C/T therapy.
![1]()
News
Weekly COVID-19 cases in children dropped 22%
January 26, 2021
One week after hitting a record high, the trend in new cases appears to return to a gradual decline.
News
Limiting antibiotic therapy after surgical drainage for native joint bacterial arthritis
January 21, 2021
Is 2 weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis noninferior to 4 weeks of antibiotic therapy?
![1]()
News
Many EM docs have treated COVID-19 patients without proper PPE: Survey
January 20, 2021
More than half of EM physicians (54%) said that they had knowingly taken personal safety risks to treat a COVID-19 emergency.
News
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
January 19, 2021
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.
![1]()
News
COVID-19 in children: Latest weekly increase is largest yet
January 19, 2021
The total number reported during Jan. 8-14 topped the previous high by almost 30,000 cases.
![1]()
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
January 15, 2021
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
![1]()
News
COVID-19 symptoms persist months after acute infection
January 14, 2021
Majority of previously hospitalized patients were experiencing fatigue or muscle weakness 6 months after discharge.
![1]()
News
Eliminating hepatitis by 2030: HHS releases new strategic plan
January 14, 2021
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C rates nearly tripled.”
